gamma capital partners

The VenturePreneurs

Skip to navigation

Skip to content

News | Contact | Opportunities | Resources |
Quote
Select your Language:
You are here: Home » Portfolio » Exited Investments » Igeneon

Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-AG

Igeneon is an Austrian biotech company and develops innovative immunotherapies against cancer (cancer vaccines). Founded in Vienna (A) as a spin-off from the Novartis-Research Centre in 1999, igeneon became a wholly owned subsidiary of Aphton Corporation, Philadelphia, PA in 2004.

Contact

igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-AG (Aphton Corp.)
Brunner Straße 69, Obj. 3
A-1230 Vienna
www.igeneon.com and www.aphton.com

News

News about Igeneon


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

main topics:

About gcp | Our Approach | Strategy | Portfolio |
Imprint

Reisnerstrasse 40/3
A-1030 Vienna

Tel.: +43 (1) 513 10 72
Fax: +43 (1) 513 10 72-200
office@gamma-capital.com
www.gamma-capital.com